Fiyinfolu (Folu) Balogun
@FiyinfoluB
Followers
285
Following
569
Media
1
Statuses
143
GI Oncologist @MSKCC. Research. Health Equity. Global Oncology. Tweets emanate from me & thus represent just me...
New York, NY
Joined November 2013
Next Friday, distinguished experts from diverse fields, institutions, and specialties will gather for our 2nd Annual #HealthEquity in Cancer Care Conference, presented by @MSKCancerCenter and MediSys Health Network. While this year’s conference has reached capacity, an on-demand
1
7
5
Adjuvant mFOLFIRINOX for Resected Pancreatic Adenocarcinoma (PDAC): Clinical Insights and Genomic Features from a Large Contemporary Cohort https://t.co/r6a7eglKZM Congrats to @ferguskeane2 @CatherineaOC @FiyinfoluB @DrewMoss for very thoughtful compilation synthesis of data!
academic.oup.com
AbstractBackground. Adjuvant modified leucovorin calcium, fluorouracil, irinotecan hydrochloride, and oxaliplatin (FOLFIRINOX) is standard of care for fit
4
28
86
Congratulations to Dr. Satish Gopal of @NCIGlobalHealth for being awarded the #ASCO24 Humanitarian Award for his unwavering efforts and dedication to reduce the burden of cancer worldwide 🌏. Congratulations to all of this year's Special Award recipients!
0
6
22
Congratulations to ACS Board Member, @DrRobWinn, on the @ASCO Allen Lichter Visionary Leader Award for his extraordinary leadership in oncology! About the award: https://t.co/QXMOEhu4pi
#ASCO24
1
9
41
Join @CentralParkWMD as he shares research from a phase I/II first-in-human study to evaluate the safety and efficacy of tissue factor-ADC MRG004A in patients with solid tumors at @ASCO. Learn more: https://t.co/e9YCtDIfaI
#ASCO24 📅: 6/1 at 3:24pm (CT)
2
8
13
The Onc Docs are back…well we never really left :) We are excited to present our discussion with Dr. Ibram X Kendi @… where he graciously shares his experience with colorectal cancer. Episode drop!
0
2
3
Join us for my oral presentation at #ASCO24 3:24 PM 6/1/2024 at Hall D1 in Chicago. 🤳@CentralParkWMD🕺🏻🪩 @ASCOPost Abstract 3002 #TF #ADC #PancreaticCancer #Developmental #Therapeutics @MSKCancerCenter 🙏 for all the pts Drs. @EileenMOReilly Zhang & Dayyani @RobinGuo5
14
8
66
We waited a few days so it wouldn't be mistaken for #AprilFools 😉. @TheOncDocs podcast is returning with award-winning author, Dr. Ibram X. Kendi @ibramxk, kicking off this new season & sharing his experience with colon #cancer. Stay tuned for the release date later this month!
0
4
13
🚀We had a great @ASCO #TECAG meeting today and had the pleasure of welcoming our guests, the @ASH_hematology Trainee Council Chair, @MayaAbdallah_MD and members of the @EuropeanCancer's Young Cancer Professional Steering Committee, @NDodlek @ElisaAgostinett!👏
2
13
43
While accounting for 3% of new cancer cases #pancreaticcancer is the 3rd leading cause for cancer mortality, w/ worse rates in patients of African ancestry. @FiyinfoluB & I are committed to finding out why & are lucky to hv @bravelikegabe support us.
The most widely cited paper of the year each year is now published for 2024. Out in @CACancerJournal from @AmericanCancer CANCER STATISTICS 2024 https://t.co/b7vWkc3A7y
#OpenAccess @OncoAlert
1
2
6
Gearing up in a few minutes to discuss advances in Colorectal Cancer put together by the wonderful folks at @CancerCare
https://t.co/GISHwmRFPo$
0
3
6
Cure4Cancer inaugural conference to advance global health equity! Tomorrow morning with a great line up of speakers! Registration is complimentary.
@AsiaPolicy @wstv_lizzi @pstAsiatech @paul_scharre 🩺On Friday, December 1, join @Cure4C, @AsiaPolicy, the Chinese Thoracic Oncology Group, and @MSKCancerCenter for the inaugural Cure4Cancer Conference: Advancing Global Health Equity & Harmonization at Asia Society in New York. RSVP for free:
1
4
13
Welcome 11/30-12/2 - HPB symposium and 12/2 Pancreas and many congratulations to @AndrewLowyMD - awardee 2023; we look forward to seeing many there! @CpcrMsk @MSK_DeptOfMed @CentralParkWMD @ciacobu @TheVinodLab @drpeterkingham @MichaelDAngeli2 @FiyinfoluB @wei_ac @OlcaBasturk
Day 3 of our #MSKHPB2023 features a #PancreasCancer Progress Update, showcasing the latest advances from the @CpcrMsk & featuring the Rubenstein Awardee, Andrew M. Lowy, MD, FACS. Join us for all 3 days or individual days. Patients & families invited. https://t.co/5eNSo7j9e6
0
8
27
Announcing the inaugural #MSKHealthEquityCME, presented by @MSKCancerCenter & MediSys Health Network — a complimentary forum to exchange and advance #cancerequity research so we can improve how we understand & address social drivers of health. Register ➡️ https://t.co/lZp1MpTzE6
0
6
22
One of our most cited article @JAMA_current Pancreatic cancer: A Review @CentralParkWMD @MDAkhilChawla @EileenMOReilly
https://t.co/g36Tmhi8iP
0
3
6
Keep those CVs coming! https://t.co/APK1PDLFX3
careercenter.asco.org
The MSK Gastrointestinal Oncology Service is seeking a full-time faculty member at the Assistant Attending level for a clinical investigator position.
@MSKCancerCenter @MSK_DeptOfMed We are hiring a physician scientist w/ focus in GI Oncology.We value academic rigor, innovation, & patient centric approach. Our research programs already helped change practice for countless individuals word-wide. Join us! https://t.co/hJutfyIJKQ
0
5
23
Thank you so much for the wonderful honor and privilege to be @PanCAN’s next Chair of the Scientific and Medical Advisory Board and to work with this amazing group of people, colleagues, friends, advocacy community and more. Thanks to everyone for all the kind words!
We're thrilled to announce Eileen M. O'Reilly, MD from @MSKCancerCenter as the new Chair of PanCAN's Scientific and Medical Advisory Board (SMAB)! Dr. O'Reilly is the principal investigator of multiple #pancreaticcancer clinical trials, including PanCAN's Precision Promise
13
29
242
We're thrilled to announce Eileen M. O'Reilly, MD from @MSKCancerCenter as the new Chair of PanCAN's Scientific and Medical Advisory Board (SMAB)! Dr. O'Reilly is the principal investigator of multiple #pancreaticcancer clinical trials, including PanCAN's Precision Promise
6
18
88
Pembro + olaparib maintenece #POLAR trial (B&C) in non-BRCA potential #HRD stage IV #PancreaticCancer n=30. Well-tolerated. 30% had no progression for > 6mo WITHOUT chemo. Deep science & POLAR A #BRCA awaited. #gratitude & 💜to MSK team & patients #ASCO23
https://t.co/kxLxxCLa4n
7
25
118
Help us enroll a study aiming to change the curative intent standard for patients with BRCA or PALB2 related #pancreaticcancer. Happy to help patients find sites near them!!
Live from @ASCO @KReissMD explains a new #clinicaltrial currently enrolling patients with early-stage #pancreaticcancer with BRCA1, BRCA2, or PALB2 mutations. #ASCO23 @PennCancer @BasserBRCA @theNCI @eaonc Learn more: https://t.co/WxpoDeFgUs
3
12
34